Use of drugs in cardiogenic shock due to acute myocardial infarction.
D000208:Acute Disease; D001794:Blood Pressure / Q000187:drug effects; D002496:Central Venous Pressure; D002746:Chlorpromazine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003911:Dextrans / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004298:Dopamine / Q000627:therapeutic use; D005934:Glucagon / Q000627:therapeutic use; D006352:Heart Ventricles / Q000503:physiopathology; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000150:complications* / Q000503:physiopathology; D009638:Norepinephrine / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D010953:Plasma Volume / Q000187:drug effects; D011651:Pulmonary Artery; D012770:Shock, Cardiogenic / Q000188:drug therapy* / Q000503:physiopathology
D003911:Dextrans; D004071:Digitalis Glycosides; D005934:Glucagon; D007545:Isoproterenol; D002746:Chlorpromazine; D004298:Dopamine; D009638:Norepinephrine; D010646:Phentolamine